BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4671960)

  • 1. Protection by desipramine of 6-hydroxydopamine induced damage to adrenergic nerve terminals in mouse heart.
    Bonagura V; Cassebaum L; Dangman K; Freund J; Cabbat F; Dembiec D; Heikkila R; Cohen G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):163-71. PubMed ID: 4671960
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 3. Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol.
    Cohen G; Heikkila RE; Allis B; Cabbat F; Dembiec D; MacNamee D; Mytilineou C; Winston B
    J Pharmacol Exp Ther; 1976 Nov; 199(2):336-52. PubMed ID: 185360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isomers of 2,4,5-trihydroxyphenethylamine (6-hydroxydopamine): long-term effects on the accumulation of (3H)-norepinephrine in mouse heart in vivo.
    Lundstrom J; Ong H; Daly J; Creveling CR
    Mol Pharmacol; 1973 Jul; 9(4):505-13. PubMed ID: 4725781
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of 6-hydroxydopamine on vagal cardioaccelerator systems.
    Alter WA; Weiss GK; Priola DV; Spurgeon HA
    J Pharmacol Exp Ther; 1973 Oct; 187(1):99-104. PubMed ID: 4746337
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the possibility of chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine (6-OH-DA)].
    Thoenen H; Tranzer JP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):212-3. PubMed ID: 4239240
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake and accumulation of 3H-6,7-dihydroxytetrahydroisoquinoline by peripheral sympathetic nerves in vivo.
    Locke S; Cohen G; Dembiec D
    J Pharmacol Exp Ther; 1973 Oct; 187(1):56-67. PubMed ID: 4746334
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté L; Cohen G
    J Neurochem; 1973 May; 20(5):1345-50. PubMed ID: 4716829
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of nicotine by the sympathetic nerve terminals in the blood vessel.
    Bevan JA; Su C
    J Pharmacol Exp Ther; 1972 Sep; 182(3):419-26. PubMed ID: 5055404
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of 6-hydroxydopamine neurotoxicity.
    Cohen G; Allis B; Winston B; Mytilineou C; Heikkila R
    Eur J Pharmacol; 1975 Aug; 33(1):217-21. PubMed ID: 1175689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
    Jonsson G
    Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake, retention and metabolism of H 3 -tyramine in rat atria.
    Steinberg MI; Smith CB
    J Pharmacol Exp Ther; 1971 Jan; 176(1):139-48. PubMed ID: 4936457
    [No Abstract]   [Full Text] [Related]  

  • 13. Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.
    Jonsson G; Sachs C
    J Pharmacol Exp Ther; 1972 Mar; 180(3):625-35. PubMed ID: 4335111
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative histofluorescent study of cardiac sympathetic nerves and adrenal catecholamines in rats under immobilization stress and administered a toxic dose of noradrenaline].
    Serov RA; Chekareva GA; Sokolova NN; Mikhaĭlenko TF
    Farmakol Toksikol; 1987; 50(4):38-41. PubMed ID: 3666114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle and gland cell degeneration in the octopus posterior salivary gland after 6-hydroxydopamine administration.
    Martin R; Barlow JJ
    J Ultrastruct Res; 1975 Aug; 52(2):167-78. PubMed ID: 1152112
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.
    Finch L; Haeusler G; Kuhn H; Thoenen H
    Br J Pharmacol; 1973 May; 48(1):59-72. PubMed ID: 4724194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic nerve cultures as a tool for the pharmacological study of sympathetic terminals.
    Mottram DR; Presley R; Lever JD; Ivens C
    Eur J Pharmacol; 1973 May; 22(2):175-80. PubMed ID: 4146007
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of 6-hydroxydopamine.
    Thoenen H; Tranzer JP
    Annu Rev Pharmacol; 1973; 13():169-80. PubMed ID: 4576887
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of axonal transport of new amine granules for 3 H-noradrenaline retention capacity of adrenergic nerve terminals.
    Häggendal J; Dahlström A
    Acta Physiol Pol; 1973; 24(1):185-92. PubMed ID: 4351939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.